SCIENCE
PIPELINE
PATIENTS / CAREGIVERS
INVESTORS / NEWS
CAREERS


Patient information

Patient education is an essential aspect of care for individuals, families, and care providers. At ARIAD, we are committed to addressing the urgent need for better sarcoma therapies and to guiding patients to resources that can help them make informed treatment decisions. The following organizations advocate for patients with sarcoma:

Sarcoma Foundation of America

www.curesarcoma.org

The Sarcoma Foundation of America (SFA) is an advocate for increased research into new and better therapies for treating patients. The SFA raises funds to provide grants for sarcoma researchers and works with public and private organizations to raise awareness of the treatment needs of sarcoma patients.

Sarcoma Alliance

www.sarcomaalliance.org

The Sarcoma Alliance is dedicated to extending and improving the lives of sarcoma patients. The Sarcoma Alliance offers a range of services, free-of-charge, including guidance about treatment options, educational resources, and peer-to-peer support.

Jennifer Hunter Yates Sarcoma Foundation (JHYSF)

www.jenniferhunteryatessarcomafoundation.org

The JHYSF was created in memory of Jennifer Hunter Yates who battled sarcoma for 17 months before dying of the disease in April 2004. The JHYSF is a tax-exempt organization created to meet the unmet needs of the sarcoma community in the New England area. Its mission is to aid in the quest for a cure for sarcoma and to help patients and families undergoing treatment for sarcoma at the Massachusetts General Hospital Cancer Center.

How AP23573 Works

ARIAD’s lead product candidate, AP23573, is a novel, potent mTOR inhibitor in development for multiple oncology indications.
VIEW VIDEO >

©2012 ARIAD Pharmaceuticals, Inc.
Terms and Conditions   Privacy Policy   Safe Harbor   Map & Directions